↓ Skip to main content

Dove Medical Press

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Overview of attention for article published in Vascular Health and Risk Management, April 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
12 Mendeley
Title
Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
Published in
Vascular Health and Risk Management, April 2012
DOI 10.2147/vhrm.s30122
Pubmed ID
Authors

Nicolas Shammas, Shammas, Nicolas Shammas, Nader, Michael Jerin, Mrad, Marogil, Dvorak, Chintalapani, Meriner, Henn

Abstract

In this study we compared the outcomes of the everolimus-eluting stent (EES) versus the zotarolimus-eluting stent (ZES) in patients treated at a tertiary medical center, with up to one year of follow-up.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 25%
Professor > Associate Professor 2 17%
Researcher 2 17%
Student > Bachelor 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 3 25%
Readers by discipline Count As %
Medicine and Dentistry 4 33%
Nursing and Health Professions 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Computer Science 1 8%
Agricultural and Biological Sciences 1 8%
Other 0 0%
Unknown 4 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2012.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from Vascular Health and Risk Management
#663
of 785 outputs
Outputs of similar age
#135,504
of 173,277 outputs
Outputs of similar age from Vascular Health and Risk Management
#12
of 14 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 785 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,277 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.